Mabanal, Jessa .

HRN: 28-60-51  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2026
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
03/20/2026
03/26/2026
IV
200mg
Q24
Oral Candidiasis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: